Repaglinide is an antidiabetic drug in the class of medications known as
meglitinides, and was invented in 1983. Repaglinide is an oral medication used
Easy to read patient leaflet for repaglinide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
PRANDIN® (repaglinide) is an oral blood glucose-lowering drug of the
meglitinide class used in the management of type 2 diabetes mellitus (also
known as ...
Dec 11, 2014 ... Information about repaglinide (Prandin), a drug prescribed for the treatment of
high blood sugar (glucose) in patient's with diabetes.
Repaglinide lowers blood glucose by encouraging your pancreas to produce
more insulin. It works quickly so is particularly helpful in controlling blood sugar ...
Jun 27, 2016 ... Repaglinide tablets are an oral antidiabetic medicine containing repaglinide
which helps your pancreas produce more insulin and thereby ...
Repaglinide induces an early insulin response to meals decreasing postprandial
blood glucose levels. It should only be taken with meals and meal-time doses ...
(repaglinide) is an oral blood glucose-lowering drug of the meglitinide class used
in ... PRANDIN tablets contain 0.5 mg, 1 mg, or 2 mg of repaglinide. In addition ...
Apr 17, 2015 ... Repaglinide (Prandin) is used to treat people with type 2 diabetes who can't
manage their condition by diet and exercise alone.
Repaglinide is an antidiabetic drug that belongs to meglitinide category. The
mechanism of action of repaglinide is to lower blood glucose levels by blocking ...